Cargando…
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
BACKGROUND: Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973937/ https://www.ncbi.nlm.nih.gov/pubmed/20942943 http://dx.doi.org/10.1186/1479-5876-8-96 |
_version_ | 1782190848730988544 |
---|---|
author | Wehrhan, Falk Hyckel, Peter Ries, Jutta Stockmann, Phillip Nkenke, Emeka Schlegel, Karl A Neukam, Friedrich W Amann, Kerstin |
author_facet | Wehrhan, Falk Hyckel, Peter Ries, Jutta Stockmann, Phillip Nkenke, Emeka Schlegel, Karl A Neukam, Friedrich W Amann, Kerstin |
author_sort | Wehrhan, Falk |
collection | PubMed |
description | BACKGROUND: Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab (anti-RANKL antibody)-related ONJ to jaws. Msx-1 is exclusively expressed in craniofacial structures and pivotal to cranial neural crest (CNC)-derived periodontal tissue remodeling. We hypothesised that Msx-1 expression might be impaired in bisphosphonate-related ONJ. The study aim was to elucidate Msx-1 and RANKL-associated signal transduction (BMP-2/4, RANKL) in ONJ-altered and healthy periodontal tissue. METHODS: Twenty ONJ and twenty non-BP exposed periodontal samples were processed for RT-PCR and immunohistochemistry. An automated staining-based alkaline phosphatase-anti-alkaline phosphatase method was used to measure the stained cells:total cell-number ratio (labelling index, Bonferroni adjustment). Real-time RT-PCR was performed on ONJ-affected and healthy jaw periodontal samples (n = 20 each) to quantitatively compare Msx-1, BMP-2, RANKL, and GAPDH mRNA levels. RESULTS: Semi-quantitative assessment of the ratio of stained cells showed decreased Msx-1 and RANKL and increased BMP-2/4 (all p < 0.05) expression in ONJ-adjacent periodontal tissue. ONJ tissue also exhibited decreased relative gene expression for Msx-1 (p < 0.03) and RANKL (p < 0.03) and increased BMP-2/4 expression (p < 0.02) compared to control. CONCLUSIONS: These results explain the sclerotic and osteopetrotic changes of periodontal tissue following BP application and substantiate clinical findings of BP-related impaired remodeling specific to periodontal tissue. RANKL suppression substantiated the clinical finding of impaired bone remodelling in BP- and aRANKL-induced ONJ-affected bone structures. Msx-1 suppression in ONJ-adjacent periodontal tissue suggested a bisphosphonate-related impairment in cellular differentiation that occurred exclusively jaw remodelling. Further research on developmental biology-related unique features of jaw bone structures will help to elucidate pathologies restricted to maxillofacial tissue. |
format | Text |
id | pubmed-2973937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29739372010-11-05 Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features Wehrhan, Falk Hyckel, Peter Ries, Jutta Stockmann, Phillip Nkenke, Emeka Schlegel, Karl A Neukam, Friedrich W Amann, Kerstin J Transl Med Research BACKGROUND: Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab (anti-RANKL antibody)-related ONJ to jaws. Msx-1 is exclusively expressed in craniofacial structures and pivotal to cranial neural crest (CNC)-derived periodontal tissue remodeling. We hypothesised that Msx-1 expression might be impaired in bisphosphonate-related ONJ. The study aim was to elucidate Msx-1 and RANKL-associated signal transduction (BMP-2/4, RANKL) in ONJ-altered and healthy periodontal tissue. METHODS: Twenty ONJ and twenty non-BP exposed periodontal samples were processed for RT-PCR and immunohistochemistry. An automated staining-based alkaline phosphatase-anti-alkaline phosphatase method was used to measure the stained cells:total cell-number ratio (labelling index, Bonferroni adjustment). Real-time RT-PCR was performed on ONJ-affected and healthy jaw periodontal samples (n = 20 each) to quantitatively compare Msx-1, BMP-2, RANKL, and GAPDH mRNA levels. RESULTS: Semi-quantitative assessment of the ratio of stained cells showed decreased Msx-1 and RANKL and increased BMP-2/4 (all p < 0.05) expression in ONJ-adjacent periodontal tissue. ONJ tissue also exhibited decreased relative gene expression for Msx-1 (p < 0.03) and RANKL (p < 0.03) and increased BMP-2/4 expression (p < 0.02) compared to control. CONCLUSIONS: These results explain the sclerotic and osteopetrotic changes of periodontal tissue following BP application and substantiate clinical findings of BP-related impaired remodeling specific to periodontal tissue. RANKL suppression substantiated the clinical finding of impaired bone remodelling in BP- and aRANKL-induced ONJ-affected bone structures. Msx-1 suppression in ONJ-adjacent periodontal tissue suggested a bisphosphonate-related impairment in cellular differentiation that occurred exclusively jaw remodelling. Further research on developmental biology-related unique features of jaw bone structures will help to elucidate pathologies restricted to maxillofacial tissue. BioMed Central 2010-10-13 /pmc/articles/PMC2973937/ /pubmed/20942943 http://dx.doi.org/10.1186/1479-5876-8-96 Text en Copyright ©2010 Wehrhan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Wehrhan, Falk Hyckel, Peter Ries, Jutta Stockmann, Phillip Nkenke, Emeka Schlegel, Karl A Neukam, Friedrich W Amann, Kerstin Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features |
title | Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features |
title_full | Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features |
title_fullStr | Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features |
title_full_unstemmed | Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features |
title_short | Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features |
title_sort | expression of msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973937/ https://www.ncbi.nlm.nih.gov/pubmed/20942943 http://dx.doi.org/10.1186/1479-5876-8-96 |
work_keys_str_mv | AT wehrhanfalk expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures AT hyckelpeter expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures AT riesjutta expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures AT stockmannphillip expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures AT nkenkeemeka expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures AT schlegelkarla expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures AT neukamfriedrichw expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures AT amannkerstin expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures |